
Leigh C. Maier
Examiner (ID: 12110, Phone: (571)272-0656 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1614, 1621, 1693 |
| Total Applications | 1395 |
| Issued Applications | 727 |
| Pending Applications | 80 |
| Abandoned Applications | 594 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9597699
[patent_doc_number] => 20140194380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'METHOD OF MANUFACTURING COMPOSITION COMPRISING LOCAL ANESTHETIC, HEPARINOID, AND BUFFER'
[patent_app_type] => utility
[patent_app_number] => 13/978441
[patent_app_country] => US
[patent_app_date] => 2012-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8849
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978441
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/978441 | METHOD OF MANUFACTURING COMPOSITION COMPRISING LOCAL ANESTHETIC, HEPARINOID, AND BUFFER | Jan 4, 2012 | Abandoned |
Array
(
[id] => 8278450
[patent_doc_number] => 20120172320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-05
[patent_title] => 'COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2'
[patent_app_type] => utility
[patent_app_number] => 13/342421
[patent_app_country] => US
[patent_app_date] => 2012-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17726
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13342421
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/342421 | COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 | Jan 2, 2012 | Abandoned |
Array
(
[id] => 9720962
[patent_doc_number] => 20140256663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'Amphotericin Analogous Compounds and Pharmaceutical Compositions Containing Them'
[patent_app_type] => utility
[patent_app_number] => 13/996889
[patent_app_country] => US
[patent_app_date] => 2011-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17558
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996889
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/996889 | Amphotericin Analogous Compounds and Pharmaceutical Compositions Containing Them | Dec 15, 2011 | Abandoned |
Array
(
[id] => 9786296
[patent_doc_number] => 20140303116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'CARNOSINE HYALURONIC ACID MIXTURES AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 13/991833
[patent_app_country] => US
[patent_app_date] => 2011-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3361
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13991833
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/991833 | Carnosine hyaluronic acid mixtures and their use | Dec 5, 2011 | Issued |
Array
(
[id] => 9026556
[patent_doc_number] => 08536138
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-17
[patent_title] => 'Treatment of pulmonary hypertension with carbonic anhydrase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/311476
[patent_app_country] => US
[patent_app_date] => 2011-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8099
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13311476
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/311476 | Treatment of pulmonary hypertension with carbonic anhydrase inhibitors | Dec 4, 2011 | Issued |
Array
(
[id] => 9339620
[patent_doc_number] => 20140066403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'HYDROPHILIC MODIFIED POLYROTAXANE COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/005137
[patent_app_country] => US
[patent_app_date] => 2011-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5643
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14005137
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/005137 | Hydrophilic modified polyrotaxane composition | Dec 4, 2011 | Issued |
Array
(
[id] => 9198782
[patent_doc_number] => 20130338097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'HISTONE INHIBITION'
[patent_app_type] => utility
[patent_app_number] => 13/990031
[patent_app_country] => US
[patent_app_date] => 2011-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20298
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13990031
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/990031 | Histone inhibition | Nov 28, 2011 | Issued |
Array
(
[id] => 8253076
[patent_doc_number] => 20120157397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'TRIMETHYLAMINE-CONTAINING COMPOUNDS FOR DIAGNOSIS AND PREDICTION OF DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/304806
[patent_app_country] => US
[patent_app_date] => 2011-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 22597
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20120157397.pdf
[firstpage_image] =>[orig_patent_app_number] => 13304806
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/304806 | Trimethylamine-containing compounds for diagnosis and prediction of disease | Nov 27, 2011 | Issued |
Array
(
[id] => 8184159
[patent_doc_number] => 20120114658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/289678
[patent_app_country] => US
[patent_app_date] => 2011-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 70950
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20120114658.pdf
[firstpage_image] =>[orig_patent_app_number] => 13289678
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/289678 | TREATMENT OF CANCER | Nov 3, 2011 | Abandoned |
Array
(
[id] => 7791589
[patent_doc_number] => 20120053145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-01
[patent_title] => 'ARIPIPRAZOLE COMPLEX FORMULATION AND METHOD'
[patent_app_type] => utility
[patent_app_number] => 13/288077
[patent_app_country] => US
[patent_app_date] => 2011-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2459
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20120053145.pdf
[firstpage_image] =>[orig_patent_app_number] => 13288077
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/288077 | ARIPIPRAZOLE COMPLEX FORMULATION AND METHOD | Nov 2, 2011 | Abandoned |
Array
(
[id] => 7818748
[patent_doc_number] => 20120065368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTICS DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 13/277780
[patent_app_country] => US
[patent_app_date] => 2011-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 37379
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065368.pdf
[firstpage_image] =>[orig_patent_app_number] => 13277780
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/277780 | Cyclodextrin-based polymers for therapeutics delivery | Oct 19, 2011 | Issued |
Array
(
[id] => 8140789
[patent_doc_number] => 20120094951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/273590
[patent_app_country] => US
[patent_app_date] => 2011-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6377
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20120094951.pdf
[firstpage_image] =>[orig_patent_app_number] => 13273590
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/273590 | COMPOSITIONS | Oct 13, 2011 | Abandoned |
Array
(
[id] => 9069313
[patent_doc_number] => 20130261070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'ANTI-EPILEPTOGENIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/877633
[patent_app_country] => US
[patent_app_date] => 2011-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4305
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877633
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/877633 | ANTI-EPILEPTOGENIC AGENTS | Oct 3, 2011 | Abandoned |
Array
(
[id] => 7733340
[patent_doc_number] => 20120015898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'COMPOUNDS AND METHODS FOR TREATMENT OF SICKLE CELL DISEASE OR COMPLICATIONS ASSOCIATED THEREWITH'
[patent_app_type] => utility
[patent_app_number] => 13/243873
[patent_app_country] => US
[patent_app_date] => 2011-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4057
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015898.pdf
[firstpage_image] =>[orig_patent_app_number] => 13243873
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/243873 | Compounds and methods for treatment of sickle cell or complications associated therewith | Sep 22, 2011 | Issued |
Array
(
[id] => 7731714
[patent_doc_number] => 20120015025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'CHOLESTANOL DERIVATIVE FOR COMBINED USE'
[patent_app_type] => utility
[patent_app_number] => 13/242184
[patent_app_country] => US
[patent_app_date] => 2011-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4612
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015025.pdf
[firstpage_image] =>[orig_patent_app_number] => 13242184
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/242184 | CHOLESTANOL DERIVATIVE FOR COMBINED USE | Sep 22, 2011 | Abandoned |
Array
(
[id] => 11581734
[patent_doc_number] => 09636355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-02
[patent_title] => 'Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion'
[patent_app_type] => utility
[patent_app_number] => 13/200270
[patent_app_country] => US
[patent_app_date] => 2011-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 4848
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13200270
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/200270 | Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion | Sep 21, 2011 | Issued |
Array
(
[id] => 7719916
[patent_doc_number] => 20120009251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'CHOLESTANOL DERIVATIVE FOR COMBINED USE'
[patent_app_type] => utility
[patent_app_number] => 13/235877
[patent_app_country] => US
[patent_app_date] => 2011-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4612
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20120009251.pdf
[firstpage_image] =>[orig_patent_app_number] => 13235877
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/235877 | CHOLESTANOL DERIVATIVE FOR COMBINED USE | Sep 18, 2011 | Abandoned |
| 13/199805 | Composition for the treatment and prevention of endothelial dysfunction | Sep 9, 2011 | Abandoned |
Array
(
[id] => 8892220
[patent_doc_number] => 20130165404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'HYBRID COOPERATIVE COMPLEXES OF HYALURONIC ACID'
[patent_app_type] => utility
[patent_app_number] => 13/820838
[patent_app_country] => US
[patent_app_date] => 2011-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5508
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820838
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/820838 | HYBRID COOPERATIVE COMPLEXES OF HYALURONIC ACID | Sep 8, 2011 | Abandoned |
Array
(
[id] => 8336062
[patent_doc_number] => 20120202762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'METHODS OF USE OF GLYCOMIMETICS WITH REPLACEMENTS FOR HEXOSES AND N-ACETYL HEXOSAMINES'
[patent_app_type] => utility
[patent_app_number] => 13/224847
[patent_app_country] => US
[patent_app_date] => 2011-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 35692
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13224847
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/224847 | METHODS OF USE OF GLYCOMIMETICS WITH REPLACEMENTS FOR HEXOSES AND N-ACETYL HEXOSAMINES | Sep 1, 2011 | Abandoned |